Speakers
Session 2. Imaging approaches for migration research and drug discovery
Chair: Kurt Anderson
Matt is a PhD researcher at the Institute of Cancer Research in London, focussing on 3D deep learning techniques applied to cancer biology. Matt’s research attempts to predict the heterogeneous response to therapy in 3D cancer models and to use this knowledge to design novel therapies targeting resistant cells. This will shed light on previously unknown biology, allowing better cancer therapy and ultimately saving lives. He is also a visiting researcher at Imperial College London and The Francis Crick Institute and an Enrichment Student at the Alan Turing Institute. Matt obtained a BSc (Hons) degree in statistics from the University of Cape Town (South Africa) and an MSc in artificial intelligence from the University of Southampton.
Matt and his supervisor, Professor Chris Bakal, have started a company called Sentinal 4D which aims to predict the likelihood of success of cancer drugs in clinical trials based on the morphology of drug-treated cancer models. He has been awarded Cancer Tech Accelerator grant funding and has been shortlisted for the Cancer Research Horizons Early-Career Entrepreneur of the Year award.